[1] Rootman D B, Mavrikakis I, Connors J M, et al. Primary, unilateral ocular adnexal lymphoma: disease progression and long-term survival[J]. Ophthal plast Reconstr Surg, 2011,27(6):405-409. [2] Jakobiec F A. Ocular adnexal lymphoid tumors: progress in need of clarification[J]. Am J Ophthalmol, 2008,145(6):941-950. [3] Sullivan T J, Whitehead K, Williamson R, et al. Lymphoproliferative disease of the ocular adnexa: a clinical and pathologic study with statistical analysis of 69 patients[J]. Ophthal Plast Reconstr Surg, 2005,21(3):177-188. [4] Vose J M. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinnical management[J]. Am J Hematol, 2012,87(6):604-609. [5] Sharara N, Holden J T, Wojno T H, et al. Ocular adnexal lymphoid proliferations: clinical, histologic, flow cytometric and molecular analysis of 43 cases[J]. Ophthalmology, 2003,110(6):1245-1254. [6] Demirci H, Shields C L, Karatza E C, et al. Orbital lymphoproliferative tumors: analysis of clinical features and systemic involvement in 160 cases[J]. Ophthalmology, 2008,115(9):1626-1631. [7] Gruenberger B, Woehrer S, Troch M, et al. Assessment of the role of hepatitis C, helicobacter pylori and autoimmunity in MALT lymphoma of the ocular adnexa in 45 Austrian patients[J]. Acta Oncol, 2008,47(3):355-359. [8] 黄宗明,于媛媛,李友红.67例眼眶淋巴组织增生性病变病理学与免疫表型分析[J].福建医药杂志,2010,2,87-88. [9] 徐玲,蒋永强,吴晓梅,等.眼附属器恶性淋巴瘤172例临床病理分析[J].眼科新进展,2011,3:254-257. [10] Ferry J A, Fung C Y, Zukerberg L, et al. Lymphoma of the ocular adnexa: a study of 353 cases[J]. Am J Surg Pathol, 2007,31(2):170-184. [11] Coupland S E, Hellmich M, Auw-Haedrich C, et al. Plasmacellular differentiation in extranodal marginal zone B-cell lymphomas of the ocular adnexa: an analysis of the neoplastic plasma cell phenotype and its prognostic significance in 136 cases[J]. Br J Ophthalmol, 2005,89(3):352-359. [12] Tanimoto K, Kaneko A, Suzuki S, et al. Primary ocular adnexal MALT lymphoma: a long-term follow-up study of 114 patients[J]. Jpn J Clin Oncol, 2007,37(5):337-344. [13] Ferreri A J, Dolcetti R, Du M Q, et al.Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy[J]. Ann Oncol, 2008,19(5):835-846. [14] Lagoo A S, Haggerty C, Kim Y, et al. Morphologic features of 115 lymphomas of the orbit and ocular adnexa categorized according to the World Health Organization classification: are marginal zone lymphomas in the orbit mucosa-associated lymphoid tissue type lymphomas[J]. Arch Pathol Lab Med, 2008,132(9):1405-1416. [15] Mozos A, Royo C, Hartmann E, et al. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype[J]. Haematologica, 2009,94(11):1555-1562. [16] Ruiz A, Reischl U, Swerdlow S H, et al. Extranodal marginal zone B-cell lymphomas of the ocular adnexa. Multiparameter analysis of 34 cases including interphase molecular cytogenetics and PCR for Chlamydia psittaci[J]. Am J Surg Pathol, 2007,31(5):792-802. [17] Smiljanic M, Milosevic R, Antic D, et al. Orbital and ocular adnexal mucosa-associated lymphoid tissue(MALT) lymphoma: a single-center 10-year experience[J]. Med Oncol, 2013,30(4):722-729. [18] 孙闽,陈彦,闫卓红,等.BCL10高表达与MALT淋巴瘤发生分子机制的探讨[J].中华肿瘤防治杂志,2012,19(4):250-254. [19] 郭霜,粟占三.眼眶部位淋巴瘤15例临床病理特征[J].临床误诊误治,2011,24(3):80-81. [20] Umehara H, Okazaki K, Masaki Y, et al. A novel clinical entity, IgG4-related disease(IgG4RD): general concept and details[J]. Mod Rheumatol, 2012,22(1):1-14. [21] Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4RD), 2011[J]. Mod Rheumatol, 2012,22(1):21-30. [22] Pasquali T, Schoenfield L, Spalding S J, et al. Orbital inflammation in IgG4-related sclerosing disease[J]. Orbit, 2011,30(5):258-260. [23] Yamamoto M, Ohara M, Suzuki C, et al. Elevated IgG4 concentrations in serum of patients with Mikulicz's disease[J]. Scand J Rheumatol, 2004,33(6):432-433. [24] Yamamoto M, Takahashi H, Sugai S, et al. Clinical and pathological characteristics of Mikulicz's disease(IgG4-related plasmacytic exocrinopathy)[J]. Autoimmun Rev, 2005,4(4):195-200. |